With its newly-approved CE Mark, Denver-based company HeartHero is poised on the front lines to combat the global threat of Cardiac Death. Created by a team of medical experts and partners, Elliot’s affordable price tag and portable size help place lifesaving technology within arm’s reach for anyone, anywhere. DENVER–(BUSINESS WIRE)–Today, […]
Rhythm
GBT Tokenize to Add Blood Pressure Measurement Feature to qTerm Device
Version II Aim to Release Q1/2021 SAN DIEGO, Nov. 05, 2020 (GLOBE NEWSWIRE) — GBT Technologies Inc. (OTC PINK: GTCH) (“GBT”, or the “Company”), announced that its joint Venture GBT Tokenize Corp (“GBT/Tokenize”) is currently developing an additional feature for its qTerm device. The additional feature will be a blood […]
ABBOTT INTRODUCES NEXT-GENERATION 3D CARDIAC MAPPING PLATFORM IN EUROPE AND AUSTRALIA
– The EnSite™ X EP System is a new cardiac mapping system designed from electrophysiologist input to optimize cardiac ablation procedures – System offers electrophysiologists a new platform of options to provide consistent performance, regardless of the patient’s cardiac anatomy ABBOTT PARK, Ill., Nov. 2, 2020 — Abbott today announced it […]
Masimo Announces Limited Market Release of Radius VSM™
Versatile, Wearable Continuous Monitoring Solution Provides Masimo SET® Pulse Oximetry, Proprietary Noninvasive Blood Pressure, Body Temperature, Respiration Rate, and Electrocardiography NEUCHATEL, Switzerland–(BUSINESS WIRE)–Masimo (NASDAQ: MASI) announced today that Radius VSM™, a wearable, tetherless vital signs monitor, has received CE marking and is being released in limited European markets. The versatile, expandable Radius […]
Boston Scientific Initiates Trial to Evaluate WATCHMAN FLX™ Left Atrial Appendage Closure Device as First-Line Treatment for People at Risk of Stroke
Trial to study next-generation device as treatment alternative to NOACs for broader population of patients with non-valvular atrial fibrillation MARLBOROUGH, Mass., Oct. 29, 2020 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) has initiated the CHAMPION-AF clinical trial to evaluate the safety and efficacy of the WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) Device […]
BioSig Announces Completion of PURE EP™ System Installation at New Medical Center
First Patient Cases with PURE EP System Conducted at Deborah Heart and Lung Center Westport, CT, Oct. 29, 2020 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company developing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the […]
Maxim Integrated’s Health Sensor Platform 3.0 Reduces Development Time of Healthcare Wearables by At Least Six Months
MAXREFDES104# is a wrist form factor reference design ready to collect blood oxygen, ECG, heart rate, body temperature and activity data SAN JOSE, Calif., Oct. 28, 2020 /PRNewswire/ — Save at least six months of development time using the Health Sensor Platform 3.0 (HSP 3.0) from Maxim Integrated Products, Inc. (NASDAQ: MXIM). Also […]
Getinge launches NICCI – the latest innovation in Advanced Hemodynamic Monitoring
NICCI is Getinge’s latest innovation in Advanced Hemodynamic Monitoring, providing continuous and noninvasive hemodynamic insights to reduce the risk of severe complications for patients with low blood pressure GOTHENBURG, Sweden, Oct. 26, 2020 /PRNewswire/ — Blood pressure is one of the most important variables evaluated during almost every surgical intervention, but recent […]
GMAX Biopharm gives first does of anti-body drug treating PAH in phase 1B trial
HANGZHOU, China, Oct. 26, 2020 /PRNewswire/ — Gmax Biopharm today announces that the first dose of GMA301 was given to the patient in its phase 1B trial to investigate the drug efficacy to treat pulmonary arterial hypertension (PAH). GMA 301 is the first antibody drug for PAH treatment. In the phase 1A trial, it […]
UNC Researchers Identify Genetic Variant Linked to Drug-Induced Hypertension with Avastin®
Results from largest genomic analysis offer pathway to preventive patient screening CHAPEL HILL, N.C., Oct. 22, 2020 /PRNewswire/ — In the largest study of its kind, researchers from the University of North Carolina at Chapel Hill (UNC) have discovered a genetic variant that can be used to predict if patients will develop hypertension from […]



